S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
LON:TATE

Tate & Lyle (TATE) Share Forecast, Price & News

GBX 756
-3.00 (-0.40%)
(As of 04:38 PM ET)
Compare
Today's Range
749
760.79
50-Day Range
759
831.50
52-Week Range
647.80
837.50
Volume
2.31 million shs
Average Volume
1.12 million shs
Market Capitalization
£3.04 billion
P/E Ratio
2,438.71
Dividend Yield
2.38%
Price Target
GBX 909

Tate & Lyle MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
20.2% Upside
GBX 909 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.19 out of 5 stars


TATE stock logo

About Tate & Lyle (LON:TATE) Stock

Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The company offers texturants; nutritive sweeteners, such as high fructose corn syrup and dextrose; health and wellness ingredients; and stabilizers. It also provides industrial starches for paper, packaging, and industrial adhesives; acidulants, such as citric acid; and commodities comprising corn gluten feed and meal for animal nutrition, as well as corn oil and ethanol. In addition, the company engages in the treasury and insurance businesses; and provision of research and development services. Tate & Lyle PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

Receive TATE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tate & Lyle and its competitors with MarketBeat's FREE daily newsletter.

TATE Stock News Headlines

TLYB.SG - Tate & Lyle PLC
Wall Street Legend Warns "Mass Bank Run" is Coming
Man who predicted 2023 bank run warns it could soon get worse. Get out of cash and into a new vehicle 50 years in the making. Click here to learn more.
Tate & Lyle FY Oper Pft GBP196M
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
See More Headlines

TATE Price History

TATE Company Calendar

Today
6/09/2023
Ex-Dividend for 8/2 Dividend
6/22/2023
Dividend Payable
8/02/2023

Industry, Sector and Symbol

Industry
Packaged Foods
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
4,441
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 909
High Stock Price Forecast
GBX 975
Low Stock Price Forecast
GBX 810
Forecasted Upside/Downside
+19.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Net Income
£127 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.75 billion
Cash Flow
GBX 130.95 per share
Book Value
GBX 299 per share

Miscellaneous

Free Float
N/A
Market Cap
£3.05 billion
Optionable
Not Optionable
Beta
0.46

Key Executives

  • Mr. Nick Hampton M.A. (Age 55)
    MA (Hons), CEO & Exec. Director
    Comp: $1.49M
  • Ms. Dawn Amanda Allen (Age 54)
    CFO & Director
  • Ms. Melissa Law (Age 48)
    Pres of Global Operations
  • Mr. Christopher Marsh
    VP of Investor Relations
  • Ms. Lindsay Beardsell (Age 46)
    Exec. VP & Gen. Counsel
  • Esyllt Dafydd
    Global Corp. PR Mang.
  • Ms. Tamsin Vine
    Chief HR Officer
  • Mr. Rowan Adams
    Exec. VP of Corp. Affairs
  • Mr. Andrew Taylor
    Pres of Asia, Middle East, Africa & Latin America
  • Ms. Susanna Palatucci
    Global Head of Health & Wellness, Innovation & Commercial Devel.













TATE Stock - Frequently Asked Questions

Should I buy or sell Tate & Lyle stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tate & Lyle in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TATE shares.
View TATE analyst ratings
or view top-rated stocks.

What is Tate & Lyle's stock price forecast for 2023?

6 equities research analysts have issued 12-month price objectives for Tate & Lyle's stock. Their TATE share price forecasts range from GBX 810 to GBX 975. On average, they expect the company's stock price to reach GBX 909 in the next twelve months. This suggests a possible upside of 19.9% from the stock's current price.
View analysts price targets for TATE
or view top-rated stocks among Wall Street analysts.

How have TATE shares performed in 2023?

Tate & Lyle's stock was trading at GBX 711.20 at the beginning of the year. Since then, TATE stock has increased by 6.6% and is now trading at GBX 758.18.
View the best growth stocks for 2023 here
.

How often does Tate & Lyle pay dividends? What is the dividend yield for Tate & Lyle?

Tate & Lyle declared a dividend on Thursday, May 25th. Investors of record on Thursday, June 22nd will be paid a dividend of GBX 13.10 per share on Wednesday, August 2nd. This represents a dividend yield of 1.67%. The ex-dividend date of this dividend is Thursday, June 22nd. This is a positive change from the stock's previous dividend of GBX 5.40. The official announcement can be seen at this link.
Read our dividend analysis for TATE
.

Is Tate & Lyle a good dividend stock?

Tate & Lyle (LON:TATE) pays an annual dividend of GBX 18 per share and currently has a dividend yield of 2.34%. The dividend payout ratio is 5,806.45%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for TATE.

What other stocks do shareholders of Tate & Lyle own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tate & Lyle investors own include Barclays (BARC), Legal & General Group (LGEN), Unilever (ULVR), HSBC (HSBA), Royal Dutch Shell (RDSA), Coca-Cola HBC (CCH), Diageo (DGE), Mondelez International (MDLZ), National Grid (NG) and Sirius Minerals (SXX).

What is Tate & Lyle's stock symbol?

Tate & Lyle trades on the London Stock Exchange (LON) under the ticker symbol "TATE."

How do I buy shares of Tate & Lyle?

Shares of TATE stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Tate & Lyle's stock price today?

One share of TATE stock can currently be purchased for approximately GBX 758.18.

How much money does Tate & Lyle make?

Tate & Lyle (LON:TATE) has a market capitalization of £3.05 billion and generates £1.75 billion in revenue each year. The company earns £127 million in net income (profit) each year or GBX 0.31 on an earnings per share basis.

How many employees does Tate & Lyle have?

The company employs 4,441 workers across the globe.

How can I contact Tate & Lyle?

Tate & Lyle's mailing address is 1 Kingsway, LONDON, WC2B 6AT, United Kingdom. The official website for the company is www.tateandlyle.com. The company can be reached via phone at +44-20-72572100.

This page (LON:TATE) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -